Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department

Journal of Nephrology

Volumn 28, Issue 6, 2015, Pages 717-724

  Marino, Rossella ^a   Struck, Joachim ^b   Hartmann, Oliver ^b   Maisel, Alan S ^c   Rehfeldt, Miriam ^b   Magrini, Laura ^a   Melander, Olle ^d   Bergmann, Andreas ^b   Di Somma, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SPHINGOTEC GMBH   (Germany)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Acute kidney injury; Enkephalin; Mortality; NGAL; RIFLE; Sepsis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROCALCITONIN; PROENKEPHALIN; ACUTE PHASE PROTEIN; CREATININE; ENKEPHALIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; PROTEIN PRECURSOR;

ACUTE KIDNEY FAILURE; AGED; APACHE; ARTICLE; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSTIC ASSESSMENT; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SEPSIS; ACUTE KIDNEY INJURY; BLOOD; EMERGENCY HEALTH SERVICE; PREDICTIVE VALUE; PROGNOSIS; TIME FACTOR; URINE; VERY ELDERLY;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; CREATININE; EMERGENCY SERVICE, HOSPITAL; ENKEPHALINS; FEMALE; HUMANS; LIPOCALINS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS; RETROSPECTIVE STUDIES; SEPSIS; TIME FACTORS;

EID: 84944195742     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-014-0163-z     Document Type: Article

References (34)

1. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ (2006) Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17(4):1135–1142. doi:10.1681/ASN.2005060668
2. Joslin J, Ostermann M (2012) Care of the critically ill emergency department patient with acute kidney injury. Emerg Med Int 2012:760623. doi:10.1155/2012/760623
3. Fagugli RM, Patera F, Battistoni S, Mattozzi F, Tripepi G (2014) Six-year single-center survey on AKI requiring renal replacement therapy: epidemiology and health care organization aspects. J Nephrol. doi:10.1007/s40620-014-0114-8
4. Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Go AS (2009) Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol CJASN 4(5):891–898. doi:10.2215/CJN.05571008
5. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A (2007) Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol JASN 18(4):1292–1298. doi:10.1681/ASN.2006070756
6. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C (2006) An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 34(7):1913–1917. doi:10.1097/01.CCM.0000224227.70642.4F
7. Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM (2006) Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol JASN 17(4):1143–1150. doi:10.1681/ASN.2005091017
8. Martin GS, Mannino DM, Moss M (2006) The effect of age on the development and outcome of adult sepsis. Crit Care Med 34(1):15–21
9. Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351(2):159–169. doi:10.1056/NEJMra032401
10. Murugan R, Kellum JA (2011) Acute kidney injury: what’s the prognosis? Nat Rev Nephrol 7(4):209–217. doi:10.1038/nrneph.2011.13
11. Thakar CV, Christianson A, Freyberg R, Almenoff P, Render ML (2009) Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med 37(9):2552–2558. doi:10.1097/CCM.0b013e3181a5906f
12. Kellum JA, Lameire N, for the KAKIGWG (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17(1):204. doi:10.1186/cc11454
13. Urbschat A, Obermuller N, Haferkamp A (2011) Biomarkers of kidney injury. Biomarkers 16(Suppl 1):S22–S30. doi:10.3109/1354750X.2011.587129
14. Ronco C, Kellum JA, Haase M (2012) Subclinical AKI is still AKI. Crit Care 16(3):313. doi:10.1186/cc11240
15. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler TA, Mertens PR (2011) The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 57(17):1752–1761. doi:10.1016/j.jacc.2010.11.051
16. Hjortrup PB, Haase N, Wetterslev M, Perner A (2013) Clinical review: predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients. Crit Care 17(2):211. doi:10.1186/cc11855
17. Di Somma S, Magrini L, De Berardinis B, Marino R, Ferri E, Moscatelli P, Ballarino P, Carpinteri G, Noto P, Gliozzo B, Paladino L, Di Stasio E (2013) Additive value of blood neutrophil gelatinase-associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department. Crit Care 17(1):R29. doi:10.1186/cc12510
18. Martensson J, Bell M, Oldner A, Xu S, Venge P, Martling CR (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36(8):1333–1340. doi:10.1007/s00134-010-1887-4
19. Denning GM, Ackermann LW, Barna TJ, Armstrong JG, Stoll LL, Weintraub NL, Dickson EW (2008) Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues. Peptides 29(1):83–92. doi:10.1016/j.peptides.2007.11.004
20. Smith R, Grossman A, Gaillard R, Clement-Jones V, Ratter S, Mallinson J, Lowry PJ, Besser GM, Rees LH (1981) Studies on circulating met-enkephalin and beta-endorphin: normal subjects and patients with renal and adrenal disease. Clin Endocrinol 15(3):291–300
21. Klin M, Waluga M, Rudka R, Madej A, Janiszewska M, Grzebieniak E, Wesolowky A (1998) Plasma catecholamines, neuropeptide Y and leucine-enkephalin in uremic patients before and after dialysis during rest and handgrip. Boll Chim Farm 137(8):306–313
22. Ernst A, Kohrle J, Bergmann A (2006) Proenkephalin A 119-159, a stable proenkephalin A precursor fragment identified in human circulation. Peptides 27(7):1835–1840. doi:10.1016/j.peptides.2006.03.008
23. Ng LL, Sandhu JK, Narayan H, Quinn PA, Squire IB, Davies JE, Bergmann A, Maisel A, Jones DJ (2014) Proenkephalin and prognosis after acute myocardial infarction. J Am Coll Cardiol 63(3):280–289. doi:10.1016/j.jacc.2013.09.037
24. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines C, American Association of Critical-Care N, American College of Chest P, American College of Emergency P, Canadian Critical Care S, European Society of Clinical M, Infectious D, European Society of Intensive Care M, European Respiratory S, International Sepsis F, Japanese Association for Acute M, Japanese Society of Intensive Care M, Society of Critical Care M, Society of Hospital M, Surgical Infection S, World Federation of Societies of I, Critical Care M (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36(1):296–327. doi:10.1097/01.CCM.0000298158.12101.41
25. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative w (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8(4):R204–R212. doi:10.1186/cc2872
26. Persson M, Berglund G, Nelson JJ, Hedblad B (2008) Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a population-based cohort study from Malmo, Sweden. Atherosclerosis 200(1):191–198. doi:10.1016/j.atherosclerosis.2007.12.001
27. Yousefshahi F, Bashirzadeh M, Abdollahi M, Mojtahedzadeh M, Salehiomran A, Jalali A, Mazandarani M, Zaare E, Ahadi M (2013) Effect of hypertonic saline infusion versus normal saline on serum NGAL and cystatin C levels in patients undergoing coronary artery bypass graft. J Tehran Heart Center 8(1):21–27
28. Uchino S, Bellomo R, Bagshaw SM, Goldsmith D (2010) Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant 25(6):1833–1839. doi:10.1093/ndt/gfp624
29. Grossman A, Besser GM, Milles JJ, Baylis PH (1980) Inhibition of vasopressin release in man by an opiate peptide. Lancet 2(8204):1108–1110
30. Rosenberger J, Petrovics G, Buzas B (2001) Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38- and ERK-MAP kinases and NF-kappaB. J Neurochem 79(1):35–44
31. Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R (2008) Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 36(4 Suppl):S198–S203. doi:10.1097/CCM.0b013e318168ccd5
32. Przewlocki R, Przewlocka B (2001) Opioids in chronic pain. Eur J Pharmacol 429(1–3):79–91
33. Mercadante S, Arcuri E (2004) Opioids and renal function. The journal of pain: official journal of the American Pain Society 5(1):2–19. doi:10.1016/j.jpain.2003.09.007
34. Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, Heilberg IP (2008) Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol CJASN 3(2):348–354. doi:10.2215/CJN.02870707